lansoprazole has been researched along with Galactorrhea in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Galactorrhea: Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duwicquet, F | 1 |
Gras-Champel, V | 1 |
Masmoudi, K | 1 |
Izquierdo Prieto, OM | 1 |
Moreno Alía, E | 1 |
Rosillo González, A | 1 |
2 other studies available for lansoprazole and Galactorrhea
Article | Year |
---|---|
[Hyperprolactinemia with galactorrhea induced by lansoprazole: A case report].
Topics: Adolescent; Female; Galactorrhea; Humans; Hyperprolactinemia; Lansoprazole; Proton Pump Inhibitors | 2017 |
[Galactorrhea induced by lansoprazole].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Galactorrhea; Humans; Lansoprazole; Male; Omeprazole | 2004 |